• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Exp Med . Predicting SARS-CoV-2-specific CD4+ and CD8+ T-cell responses elicited by inactivated vaccines in healthy adults using machine learn

tetano

Editor, Senior Moderator
Clin Exp Med


. 2025 Jul 8;25(1):236.
doi: 10.1007/s10238-025-01772-2. Predicting SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cell responses elicited by inactivated vaccines in healthy adults using machine learning models

Jie Ning[SUP] 1 [/SUP], Yayi Ren[SUP] 1 [/SUP], Zelin Zhang[SUP] 1 [/SUP], Xianhuang Zeng[SUP] 1 [/SUP], Qinjin Wang[SUP] 1 [/SUP], Jia Xie[SUP] 1 [/SUP], Yue Xu[SUP] 1 [/SUP], Yali Fan[SUP] 1 [/SUP], Huilan Li[SUP] 1 [/SUP], Aixia Zhai[SUP] 1 [/SUP], Bin Li[SUP] 1 [/SUP], Chao Wu[SUP] 2 [/SUP], Ying Chen[SUP] 3 [/SUP]



Affiliations
Abstract

The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants highlights the importance of monitoring immune responses to guide vaccination strategies. Although neutralizing antibodies (NAbs) have garnered increasing attention, T-cells are crucial for conferring long-lasting immunity, especially their resilience against viral mutations. However, assessing T-cell responses clinically has been hindered by cost and complexity. In this study, we recruited a cohort of 134 healthy adults, who had been immunized with three doses of the SARS-CoV-2 inactivated vaccine. Cellular immunity elicited by a comprehensive array of overlapping peptides covering the entire sequence of the virus's structural proteins was assessed by intracellular cytokine staining (ICS). Additionally, a dataset including demographic information, routine blood indices, and immune cell indicators comprising 32 variables was collected. Multivariate analysis revealed age and days post-vaccination as key factors influencing the strength of the T-cell response. Importantly, random forest (RF) and classification and regression tree (CART) algorithms were employed, along with 8 easily accessible indicators to formulate predictive models for the SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cell responses. Besides, these models demonstrated substantial accuracy (r > 0.9) in both the training and testing sets. Our findings offer an efficient and economical methodology for evaluating the T-cell reactions in healthy adults following inactivated SARS-CoV-2 vaccination, which is visualizable and easy to use, providing a novel strategy for assessing cellular immunity after vaccination.

Keywords: Cellular immunity; Classification and regression tree; Machine learning; Random forest; SARS-CoV-2.

 
Back
Top Bottom